Skip to content

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00879944
Enrollment
409
Registered
2009-04-13
Start date
2009-05-31
Completion date
2012-07-31
Last updated
2015-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis, Atopic Dermatitis

Keywords

Psoriasis, Obesity, BMI, Atopic Dermatitis

Brief summary

The object of this research study is to examine these associations in children as very little is known about psoriasis and cardiovascular risk factors in the pediatric population.

Detailed description

Several environmental factors and comorbid conditions have been found to be associated with psoriasis in adults, including obesity, depression, smoking, and other cardiovascular risk factors such as high blood pressure. The object of this research study is to examine these associations in children as very little is known about psoriasis and cardiovascular risk factors in the pediatric population. This is a multi-center study with a planned total enrollment of about 200 subjects ages 2-17 years old with psoriasis and 100 aged-match controls. Patient and family history will be recorded. All subjects will undergo standard height, weight, blood pressure, and waist circumference (WC). For the obese and overweight subjects we will also obtain their growth charts to attempt to correlate weight gain with psoriasis onset and progression. All data will be compiled and then statistically analyzed.

Interventions

OTHERBlood pressure

Blood pressure will be measured once while patient is seated

OTHERHeight

Height will be measured in centimeters at the time of enrollment

OTHERWeight

Weight will be measured in kilograms at enrollment

OTHERBMI

Body Mass Index (BMI) will be calculated from a subject's height and weight

Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest with an inelastic measuring tape at the end of normal expiration to the nearest 0.1cm

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects must be between the ages of 5 and 17 years at the time of enrollment. * Subjects of either sex. * Subjects who have had psoriatic plaques for more than 6 months. * Subjects and guardians of minors must sign the approved IRB consent form(s) prior to initiation of the study protocol. * Subjects enrolled as non-inflammatory normal controls will carry a common non- systemic skin condition, such as acne, nevi, warts and molluscum as their main diagnosis. * Subjects enrolled as inflammatory normal controls will carry a diagnosis of moderate to severe atopic dermatitis.

Exclusion criteria

* Subjects who are unable to give informed consent or assent. * Subjects who have had psoriasis for less than 6 months. * Subjects whose condition is deemed unsafe or incapable by the study investigator for study participation.

Design outcomes

Primary

MeasureTime frame
BMI07/2010

Secondary

MeasureTime frame
Blood Pressure07/2010
Waist circumference07/2010

Countries

Canada, Chile, Hong Kong, Italy, Netherlands, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026